Psychological and ethical considerations in screening for disease

Area of Science:

• Cardiovascular Medicine
• Public Health Screening

Background:

• Coronary artery disease (CAD) is a leading cause of mortality in the US.
• Serum cholesterol testing is a common screening method for identifying individuals at high risk for CAD, including familial hypercholesterolemia.
• Universal screening of healthy individuals carries potential risks.

Purpose of the Study:

• To evaluate the potential risks associated with universal serum cholesterol screening.
• To identify necessary safeguards before implementing widespread screening programs.
• To inform physicians and the public about the benefits and harms of screening.

Main Methods:

• Review of previous screening program experiences (e.g., sickle cell anemia, hypertension).
• Analysis of potential harms: misunderstanding results, misdiagnosis, labeling, stigmatization, psychological distress, and misuse of data by industry/insurers.
• Identification of essential safeguards for effective and ethical screening.

Main Results:

• Screening risks include psychological harm, misdiagnosis, and potential discrimination.
• Misuse of screening results by insurance companies or employers is a significant concern.
• Lack of safeguards can lead to negative consequences for screened individuals.

Conclusions:

• Screening for coronary artery disease via serum cholesterol should not be implemented without robust safeguards.
• Essential safeguards include public and physician education, accurate and validated tests, informed consent, accessible follow-up care, and privacy protections.
• Proactive measures are crucial to mitigate risks and ensure equitable benefits from screening programs.